J Breast Cancer.  2013 Jun;16(2):159-163. 10.4048/jbc.2013.16.2.159.

Lecithin: Cholesterol Acyltransferase and Na(+)-K(+)-ATPase Activity in Patients with Breast Cancer

• Ozmen HK
• Askin S

• KMID: 2286395
• DOI: http://doi.org/10.4048/jbc.2013.16.2.159

Abstract

PURPOSE
The aim of this study was to determine whether plasma lecithin:cholesterol acyltransferase (pLCAT) and erythrocyte membrane Na(+)-K(+)-ATPase ase (emNaKATPs) activity have a correlation in breast cancer. This study compared these parameters at time points before and after treatment with radiotherapy.
METHODS
The levels of pLCAT and emNaKATPs were assessed in 30 patients with breast carcinoma and 20 control subjects. While emNaKATPs was measured with spectrophotometric method, pLCAT levels was measured using a specific enzyme-linked immunosorbent assay.
RESULTS
pLCAT levels, both before and after radiotherapy, were found to be decreased in breast cancer patients than in the controls groups (p<0.001 and p<0.001, respectively). Also, pLCAT levels after radiotherapy were found to be decreased in breast cancer patients than the pLCAT levels before radiotherapy (p<0.001). The emNaKATPs activity were higher in the control group than in the breast cancer patients before/after radiotherapy (RT) (p<0.001 and p<0.001, respectively). At the same time, emNaKATPs activity before RT was higher in the breast cancer patients than emNaKATPs activity after RT (p<0.001). There was a significant correlation between pLCAT and emNaKATPs activity in breast cancer patients receiving radiotherapy (r=0.63, p<0.001), but no correlation between in breast cancer patients before RT and control group (r=0.023, p>0.05).
CONCLUSION
The results of the present study demonstrated that decreased pLCAT and emNaKATPs activity levels in breast cancer patients after/before RT than control group. In addition, decreased emNaKATPs activity in breast cancer patients receiving radiotherapy may be due to decreased pLCAT concentrations and RT beam. In our opinion, altered activities of pLCAT and emNaKATPs are linked to the treatment effect of radiotherapy. These data may clarify the development of cell membrane dysfunction and lipid metabolism in breast cancer patients receiving radiotherapy.

Keyword

Acytransferases; Breast neoplasms; Lecithins; Na(+)-K(+)-ATPase; Radiotherapy

MeSH Terms

Breast
Breast Neoplasms
Cell Membrane
Cholesterol
Erythrocyte Membrane
Humans
Lecithins
Lipid Metabolism
Plasma
Sterol O-Acyltransferase
Cholesterol
Lecithins
Sterol O-Acyltransferase

Reference

1. Hall EJ. Radiation, the two-edged sword: cancer risks at high and low doses. Cancer J. 2000; 6:343–350.

2. Hogle WP. The state of the art in radiation therapy. Semin Oncol Nurs. 2006; 22:212–220.

3. Dainiak N, Waselenko JK, Armitage JO, MacVittie TJ, Farese AM. The hematologist and radiation casualties. Hematology Am Soc Hematol Educ Program. 2003; 473–496.

4. Jonas A. Lecithin cholesterol acyltransferase. Biochim Biophys Acta. 2000; 1529:245–256.

5. Yang CY, Manoogian D, Pao Q, Lee FS, Knapp RD, Gotto AM Jr, et al. Lecithin:cholesterol acyltransferase. Functional regions and a structural model of the enzyme. J Biol Chem. 1987; 262:3086–3091.

6. Liu M, Subbaiah PV. Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase. Proc Natl Acad Sci U S A. 1994; 91:6035–6039.

7. Goyal J, Wang K, Liu M, Subbaiah PV. Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation. J Biol Chem. 1997; 272:16231–16239.

8. Subramanian VS, Goyal J, Miwa M, Sugatami J, Akiyama M, Liu M, et al. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma. Biochim Biophys Acta. 1999; 1439:95–109.

9. Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2001; 21:481–488.

10. Clausen T. Na⁺-K⁺- pump regulation and skeletal muscle contractility. Physiol Rev. 2003; 83:1269–1324.

11. Wood L, Beutler E. Temperature dependence of sodium-potassium activated erythrocyte adenosine triphosphatase. J Lab Clin Med. 1967; 70:287–294.

12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193:265–275.

13. Muriel P, Mourelle M. The role of membrane composition in ATPase activities of cirrhotic rat liver: effect of silymarin. J Appl Toxicol. 1990; 10:281–284.

14. Muñoz MA, Balón M, Fernandez C. Direct determination of inorganic phosphorus in serum with a single reagent. Clin Chem. 1983; 29:372–374.

15. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995; 36:211–228.

16. Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968; 9:155–167.

17. Murphy JR. Erythrocyte metabolism. IV. Equilibration of cholesterol-4-C-14 between erythrocytes and variously treated sera. J Lab Clin Med. 1962; 60:571–578.

18. Czarnecka H, Yokoyama S. Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange. J Biol Chem. 1996; 271:2023–2028.

19. Sutherland WH, Temple WA, Nye ER, Herbison PG. Lecithin: cholesterol acyltransferase activity, plasma and lipoprotein lipids and obesity in men and women. Atherosclerosis. 1979; 34:319–327.

20. Magkos F, Mohammed BS, Mittendorfer B. Plasma lipid transfer enzymes in non-diabetic lean and obese men and women. Lipids. 2009; 44:459–464.

21. Perumal SS, Shanthi P, Sachdanandam P. Energy-modulating vitamins: a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma. Br J Nutr. 2005; 93:901–909.

22. Finotti P, Palatini P. Reduction of erythrocyte (Na+-K+-)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. Diabetologia. 1986; 29:623–628.

23. Testa I, Rabini RA, Fumelli P, Bertoli E, Mazzanti L. Abnormal membrane fluidity and acetylcholinesterase activity in erythrocytes from insulin-dependent diabetic patients. J Clin Endocrinol Metab. 1988; 67:1129–1133.

24. Pang D, Winters TA, Jung M, Purkayastha S, Cavalli LR, Chasovkikh S, et al. Radiation-generated short DNA fragments may perturb non-homologous end-joining and induce genomic instability. J Radiat Res. 2011; 52:309–319.

25. Buonanno M, de Toledo SM, Pain D, Azzam EI. Long-term consequences of radiation-induced bystander effects depend on radiation quality and dose and correlate with oxidative stress. Radiat Res. 2011; 175:405–415.